تقييم النتائج العلاجية لكل من المترونيدازول جيل (%0.8)والإريثرومايسين جيل(%4) والبيموكروليموس كريم(1%) في التهاب الجلد حول الفم
Abstract
شملت هذه الدراسة 120 مريض التهاب جلد حول الفم, وزعوا إلى ثلاث مجموعات ضمت كل مجموعة40 مريضاً. طبق المترونيدازول جيل(%0.8) لدى المجموعة الأولى مرتين يوميا ولمدة أربعة أسابيع ، بينما طبق الإريثرومايسين جيل(%4) لدى المجموعة الثانية، والبيموكروليموس كريم(%1) لدى المجموعة الثالثة بنفس الطريقة ولنفس الفترة الزمنية.
تم إعادة التقييم السريري في اليوم: 22 , 15 , 8 أثناء العلاج وعند نهاية العلاج( اليوم 29). كما تم متابعة المرضى سريريا بزيارات دورية مرة كل شهر لمدة ستة أشهر بعد إيقاف العلاج.
أظهرت دراستنا تفوقاً ملحوظاً للبيموكروليموس على كل من الإريثرومايسين والمترونيدازول في النتائج العلاجية وكذلك في المحافظة على هذه النتائج بعد انتهاء المعالجة.
This study included 120 patients with perioral dermatitis, who were divided into three groups, each group included 40 patients. Metronidazole gel(0.8%) has been applied on the first group twice a day for 4 weeks, whereas erythromycin gel (4%) has been applied on the second group and pimocrolimus cream (1%) on the third; in the same way and for the same period.
Clinical re-evaluation has been done at days: 8, 15,22 of treatment and at the end of treatment(day 29).We followed the patients clinically by regular visits monthly for 6 months after stopping treatment.
Our study revealed that results of pimocrolimus were better than each of erythromycin and metronidazole in the treatment and stabilization after treatment of perioral dermatitis.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series
Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in Tishreen University Journal for Research and Scientific Studies - Health Sciences Series . The Readers have the right to send, print and subscribe to the initial version of the article, and the title of Tishreen University Journal for Research and Scientific Studies - Health Sciences Series Publisher
journal uses a CC BY-NC-SA license which mean
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.